Julie Labonté

597 total citations
15 papers, 480 citations indexed

About

Julie Labonté is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Julie Labonté has authored 15 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in Julie Labonté's work include Nitric Oxide and Endothelin Effects (10 papers), Receptor Mechanisms and Signaling (6 papers) and Renin-Angiotensin System Studies (6 papers). Julie Labonté is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Receptor Mechanisms and Signaling (6 papers) and Renin-Angiotensin System Studies (6 papers). Julie Labonté collaborates with scholars based in Canada, United States and Sweden. Julie Labonté's co-authors include Pedro D’Orléans-Juste, Jean‐Claude Honoré, Ghassan Bkaily, Sanaa Choufani, Ewa Carrier, Nathalie Berthiaume, Masashi Yanagisawa, Rania Harfouche, Sabah N. A. Hussain and Jill Rudkowski and has published in prestigious journals such as Circulation, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Julie Labonté

15 papers receiving 472 citations

Peers

Countries citing papers authored by Julie Labonté

Since Specialization

Citations

This map shows the geographic impact of Julie Labonté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Labonté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Labonté more than expected).

Fields of papers citing papers by Julie Labonté

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Labonté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Labonté. The network helps show where Julie Labonté may publish in the future.

Co-authorship network of co-authors of Julie Labonté

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Labonté. A scholar is included among the top collaborators of Julie Labonté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Labonté. Julie Labonté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Chymase inhibitor-sensitive synthesis of endothelin-1 (1–31) by recombinant mouse mast cell protease 4 and human chymase 2015 ·Biochemical Pharmacology ·(unknown), (unknown), M Houde, Julie Labonté, Hugo Gagnon, Daisuke Yamamoto, Shinji Takai, Tanya M. Laidlaw, Ghassan Bkaily, Adel Schwertani, Gunnar Pejler, Christine Levesque, Roxane Desjardins, Robert Day, Pedro D’Orléans-Juste	16
2	Pivotal Role of Mouse Mast Cell Protease 4 in the Conversion and Pressor Properties of Big-Endothelin-1 2013 ·Journal of Pharmacology and Experimental Therapeutics ·M Houde, (unknown), Julie Labonté, (unknown), Gunnar Pejler, Michael F. Gurish, Shinji Takai, Pedro D’Orléans-Juste	20
3	Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist 2013 ·Biological Chemistry ·Martin Savard, Julie Labonté, Céléna Dubuc, Witold Neugebauer, Pedro D’Orléans-Juste, Fernand Gobeil	16
4	Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology 2011 ·Current Pharmaceutical Design ·M Houde, Julie Labonté, Pedro D’Orléans-Juste	7
5	Distinct modulation of the endothelin-1 pathway iniNOS^−/−andeNOS^−/−miceThis article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin. 2008 ·Canadian Journal of Physiology and Pharmacology ·Julie Labonté, (unknown), (unknown), Pedro D’Orléans-Juste	5
6	Concomitant antagonism of endothelial and vascular smooth muscle cell ET_Breceptors for endothelin induces hypertension in the hamster 2005 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jean‐Claude Honoré, (unknown), (unknown), Julie Labonté, Ghassan Bkaily, Pedro D’Orléans-Juste	21
7	Tissue-Engineered Human Vascular Media With a Functional Endothelin System 2005 ·Circulation ·(unknown), Charles J. Roberge, Julie Labonté, (unknown), Pedro D’Orléans-Juste, François A. Auger, Lucie Germain	28
8	Endothelin-1 (1-31) Is an Intermediate in the Production of Endothelin-1 After Big Endothelin-1 Administration In Vivo 2005 ·Hypertension ·(unknown), Jean‐Claude Honoré, (unknown), Julie Labonté, Giles A. Rae, Pedro D’Orléans-Juste	34
9	Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis 2004 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Jill Rudkowski, Esther Barreiro, Rania Harfouche, Peter Goldberg, (unknown), Pedro D’Orléans-Juste, Julie Labonté, Olivier Lesur, Sabah N. A. Hussain	61
10	Synthesis and degradation of endothelin-1 2003 ·Canadian Journal of Physiology and Pharmacology ·Pedro D’Orléans-Juste, (unknown), Jean‐Claude Honoré, Ewa Carrier, Julie Labonté	70
11	Function of the endothelinB receptor in cardiovascular physiology and pathophysiology 2002 ·Pharmacology & Therapeutics ·Pedro D’Orléans-Juste, Julie Labonté, Ghassan Bkaily, Sanaa Choufani, (unknown), Jean‐Claude Honoré	125
12	Role of endothelin receptors in the hypertensive state of kinin B2 knockout mice subjected to a high-salt diet 2002 ·Clinical Science ·(unknown), Julie Labonté, Ghassan Bkaily, Pedro D’Orléans-Juste	15
13	Role of ET_Band B₂receptors in theex vivoplatelet inhibitory properties of endothelin and bradykinin in the mouse 2001 ·British Journal of Pharmacology ·Julie Labonté, (unknown), Jean‐Claude Honoré, Pedro D’Orléans-Juste	16
14	Endothelin-B-Receptors-Dependent-Inhibition of Platelet Aggregation in the CD-1 Mouse 2000 ·Journal of Cardiovascular Pharmacology ·Julie Labonté, Ghassan Bkaily, Pedro D’Orléans-Juste	4
15	Heterozygous Knock-Out of ET _B Receptors Induces BQ-123–Sensitive Hypertension in the Mouse 2000 ·Hypertension ·Nathalie Berthiaume, Masashi Yanagisawa, Julie Labonté, Pedro D’Orléans-Juste	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact